Aditxt, Inc. (NASDAQ:ADTX) Sees Significant Growth in Short Interest

Aditxt, Inc. (NASDAQ:ADTX) was the target of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 1,160,000 shares, a growth of 1,070.5% from the December 15th total of 99,100 shares. Based on an average daily trading volume, of 5,450,000 shares, the short-interest ratio is presently 0.2 days. Currently, 8.2% of the shares of the company are sold short.

Aditxt Stock Down 11.1 %

Shares of ADTX stock traded down $0.02 during mid-day trading on Monday, hitting $0.15. The stock had a trading volume of 46,072,312 shares, compared to its average volume of 28,812,113. The company’s 50-day simple moving average is $0.30 and its 200-day simple moving average is $19.48. Aditxt has a fifty-two week low of $0.15 and a fifty-two week high of $218.00.

Insider Transactions at Aditxt

In related news, major shareholder Financial Lp Hrt sold 25,534 shares of the stock in a transaction on Wednesday, October 16th. The stock was sold at an average price of $1.17, for a total transaction of $29,874.78. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 1.72% of the company’s stock.

About Aditxt

Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.